Xtandi 40 MG tablet 120S
Ended Awarded
- Contract number
- SPE2DX25F6XSE
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $4,170
Award facts
- Contract value 100% obligated
- $4,169.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $4,169.59 for 120 tablets of Xtandi 40 mg, a prescription medication commonly used in oncology treatment. The award was issued on September 4, 2025, with an ultimate completion date of September 5, 2025, under a firm fixed-price contract type with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting medical supply needs across Department of Defense healthcare facilities.
The funding agency for this award is the Medical Supply Chain, a defense-oriented component within the federal government's pharmaceutical procurement structure. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, consistently securing contracts to deliver branded and generic prescription drugs, biologics, and medical consumables to military health facilities nationwide. The firm's extensive contract portfolio with the Defense Logistics Agency demonstrates its capability to reliably distribute specialized pharmaceutical products, including oncology treatments like Xtandi, directly to Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DX25F6XSE?
SPE2DX25F6XSE was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 4, 2025.
How much is contract SPE2DX25F6XSE worth?
The government has obligated $4,170 on SPE2DX25F6XSE.
Is contract SPE2DX25F6XSE an order under another contract?
Yes. SPE2DX25F6XSE is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XSE competed?
The extent of competition for SPE2DX25F6XSE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award